Or Refractory Nk T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Or Refractory Nk T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Tislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating tislelizumab plus zeprumetostat for relapsed or refractory NK/T-cell lymphoma is listed as not yet rec…